Prevention and control of hepatitis B virus infection in Singapore

Annals of the Academy of Medicine Singapore

Volumn 26, Issue 5, 1997, Pages 671-681

  Goh, K T ^a,b,c  

^a Quarantine and Epidemiol Department

^b Inst of Environmental Epidemiology

^c Quarantine and Epidemiol Department   (Singapore)

Author keywords

Immunisation; Seroepidemiology; Transmission; Vaccine trials

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN;

ADOLESCENT; ADULT; CHILD; DEMOGRAPHY; DISEASE CARRIER; DRUG EFFICACY; FEMALE; HEPATITIS B; HUMAN; IMMUNIZATION; INCIDENCE; INFANT; INFECTION CONTROL; MALE; NEWBORN; PREVALENCE; REVIEW; SINGAPORE; VIRUS TRANSMISSION;

AGE FACTORS; DISEASE TRANSMISSION, HORIZONTAL; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; SINGAPORE;

EID: 0031457790     PISSN: 03044602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (87)

1. Goh K T. Epidemiology of acute viral hepatitis in Singapore. Southeast Asian J Trop Med Public Health 1977; 8:289-97.
2. Goh K T. Hepatitis B surveillance in Singapore. Ann Acad Med Singapore 1980; 9:136-41.
3. Chan S H, Oon C J. Epidemiology of HBV infection in Singapore. Asian Pac J Allergy Immunol 1984; 2:139-43
4. Shanmugaratnam K, Lee H P, Day N E. Cancer incidence in Singapore, 1968-1977. Lyon. IARC Scientific Publication No 47, 1983.
5. Lee H P, Day N E, Shanmugaratnam K. Trends in cancer incidence in Singapore, 1968-1982. Lyon. IARC Scientific Publication No 91, 1988.
6. Committee on Epidemic Diseases Recommended screening schedule for hepatitis B virus carriers for early hepatocellular carcinoma. Epidemiol News Bull 1987, 13.65-6
7. Goh K T. Epidemiology and control of hepatitis B virus infection in Singapore. Tokyo: Southeast Asian Medical Information Center, 1992.32-52.
8. Goh K T Epidemiological surveillance of communicable diseases in Singapore. Tokyo: Southeast Asian Medical Information Center, 1983:133-9
9. Redeker A G. Viral hepatitis: clinical aspects. Am J Med Sci 1975; 270:9-16
10. Tan C C, Guan R, Yap I, Tay H H, Kang J Y. Horizontal or vertical transmission of hepatitis B virus? A serological survey in family members of hepatitis B carriers in Singapore. Trans R Soc Trop Med Hyg 1991; 85 656-9.
11. Ng H W Liver dysfunction in haemophilia A, B and other hereditary haemorrhagic disorders. Ann Acad Med Singapore 1984; 13 524-6.
12. Goh C L, Rajan V S, Chan S H, Kamarudin A. Hepatitis B infection in prostitutes. Int J Epidemiol 1986; 15:112-5
13. Goh C L, Kamarudin A, Chan S H, Rajan V S. Hepatitis B virus markers in prostitutes in Singapore Genitourin Med 1985, 61.127-9
14. Tey B H, Oon C J, Kua E H, Kueh Y K, Wong Y W, Chin J H. Prevalence of hepatitis B markers in psychiatric in-patients in Singapore: a pilot study. Ann Acad Med Singapore 1987, 16:608-11.
15. Committee on Epidemic Diseases. Prevalence of hepatitis B virus markers in an institution for the mentally handicapped. Epidemiol News Bull 1988; 14 58-9
16. Oon C J, Chan L, Guan R. Hepatitis vaccination policy for hospital staff. Lancet 1983; 1:1272.
17. Committee on Epidemic Diseases. Seroepidemiological survey of hepatitis B virus markers in school children. Epidemiol News Bull 1988; 14 56-8
18. Committee on Epidemic Diseases. Prevalence of hepatitis B virus infection in intellectually disabled school children. Epidemiol News Bull 1992; 18:28-9.
19. Lam S K, Quak S H, Raman G V, Teo J, Wong H B, Oon C J.Serological survey on hepatitis A and hepatitis B infections among the residents of social welfare homes in Singapore. J Gastroenterol Hepatol 1987; 2:213-6.
20. Goh K T, Chan Y W, Wong L Y M, Kong K H, Oon C J, Guan R. The prevalence of hepatitis B virus markers in dental personnel in Singapore. Trans R Soc Trop Med Hyg 1988, 82.908-10
21. Quak S H, Singh R, Oon C J, Wong H B. A cross-sectional study of hepatitis B immune status in Asian children. Ann Trop Paediatr 1982; 2:53-6.
22. Quak S H, Singh R, Oon C J, Wong H B The immune status of Singapore children to hepatitis B virus. Aust Paediatr J 1983; 19:100-3.
23. Yap E H, Ong Y W, Simons M J, Okochi K, Mayumi M, Nishioka K. Australia antigen in Singapore II: differential frequency in Chinese, Malays and Indians. Vox Sang 1972, 22 371-5.
24. Simons M J, Yu M, Shanmugaratnam K. Hepatitis B antigenaemia, specific immune deficiency and hepatocellular carcinoma. Tumour Res 1973; 8:120-6.
25. World Health Organization. Advances in viral hepatitis - Report of WHO Expert Committee on viral hepatitis. Geneva: WHO, 1977:38-42. WHO Tech Rep Ser No 602.
26. Szmuness W, Harley E J, Ikram H, Stevens C E Socio-demographic aspects of the epidemiology of hepatitis B. In. Vyas G N, Cohen S N, Schmid R, editors Viral Hepatitis: A Contemporary Assessment of Etiology, Epidemiology, Pathogenesis and Prevention. Philadelphia: Franklin Institute Press, 1978.297-320.
27. Phoon W O, Fong N P, Lee J, Leong H K A study on the prevalence of hepatitis B surface antigen among Chinese adult males in Singapore. Int J Epidemiol 1987; 16:74-8.
28. Szmuness W, Prince A M, Hirsch R L, Brotman B. Familial clustering of hepatitis B infection. N Engl J Med 1973; 289:1162-6
29. Perrillo R P, Gelb L, Campbell C, Wellinghoff W, Ellis F R, Overby L, et al Hepatitis e antigen, DNA polymerase activity and infection of household contacts with hepatitis B virus. Gastroenterology 1979; 76:1319-25.
30. Peters C J, Purcell R H, Lander J J, Johnson K M Radioimmunoassay for antibody to hepatitis B surface antigen shows transmission of hepatitis B virus among household contacts. J Infect Dis 1974; 134:218-23.
31. Szmuness W, Harley E J, Prince A M. Intrafamilial spread of asymptomatic hepatitis B. Am J Med Sci 1975; 223 270-304.
32. Chan S H, Tan K L, Goh K T, Lim C, Tsakok M, Oon C J, et al. Maternal-child hepatitis B virus transmission in Singapore Int J Epidemiol 1985,14.173-7.
33. Dienhardt F. Predictive value of markers of hepatitis B virus infection. J Infect Dis 1980; 141:299-305.
34. Ohbayashi A, Matsuo Y, Mozai T, Imai M, Mayumi M. Decreasing frequency of e antigen with age in serum of symptom-free carriers of hepatitis B antigen Lancet 1976; 2.577-8.
35. Tsukuma H, Oshima A, Hiyama T, Fujimoto I, Yamano H, Tanaka M. Time trends of the prevalence of hepatitis B e antigen positives among hepatitis B virus carriers in Japan Int J Epidemiol 1987, 16:579-83
36. Wainwright R B, McMahon B J, Bender T R, Heyward W, Nakanishi S, Wainwright K Y, et al Prevalence of hepatitis B virus infection in Tonga: identifying high risk groups for immunisation with hepatitis B vaccine. Int J Epidemiol 1986; 15.567-71.
37. Szmuness W, Neurath A R, Stricks N, Harley E J. Prevalence of hepatitis B 'e' antigen in various HBsAg carrier populations. Am J Epidemiol 1981; 113:113-21.
38. Alward W L M, McMahon B J, Hall D B, Heyward W L, Francis D P, Bender T R. The long-term serological course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma. J Infect Dis 1985; 151:604-9.
39. Goh K T, Ding J L, Monteiro E H, Oon C J Hepatitis B infection in households of acute cases J Epidemiol Community Health 1985; 39:123-8.
40. Bernier R H, Sampliner R, Gerety R, Tabor E, Hamilton F, Nathanson M. Hepatitis B infection in households of chronic carriers of hepatitis B surface antigen: factors associated with prevalence of infection. Am J Epidemiol 1982, 116:199-211.
41. Heathcote J, Sherlock S. Spread of acute type-B hepatitis in London Lancet 1973, 1:1468-70
42. Wright R A. Hepatitis B and the HBsAg carrier an outbreak related to sexual contact. JAMA 1975, 232 717-21.
43. Redeker A G, Mosley J W, Gocke D J, Mckee A P, Pollack W. Hepatitis B immune globulin as a prophylactic measure for spouses exposed to acute type B hepatitis. N Engl J Med 1975; 293:1055-9.
44. Heng B H, Goh K T, Chan R, Chew S K, Doraisingham S, Quek G H Prevalence of hepatitis B virus (HBV) infection in Singapore men with sexually transmitted diseases and HIV infection: role of sexual transmission in a city state with intermediate HBV endemicity. J Epidemiol Community Health 1995; 49:309-13.
45. Byrom N A, Davidson G, Draper C C, Zuckerman A J. Role of mosquitoes in transmission of hepatitis B antigen. J Infect Dis 1973; 128:259-60.
46. Berquist K R, Maynard J E, Francy D B, Sheller M J, Schable C A. Experimental studies on the transmission of hepatitis B by mosquitoes. Am J Trop Med Hyg 1976; 25:730-2.
47. Szmuness W, Stevens C E, Harley E J, Zang E A, Oleszko W R, William D C, et al. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med 1980; 303:833-41.
48. Beasley R P, Hwang L Y, Lee G C Y, Lan C C, Roan C H, Huang F Y, et al. Prevention of perinatally transmitted hepatitis B virus infection with hepatitis B immunoglobulin and hepatitis B vaccine Lancet 1983; 2:1009-102.
49. Stevens C E, Taylor P E, Tong M J, Toy P T, Vyas G N, Nair P V, et al. Yeast-recombinant hepatitis B vaccine: efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission. JAMA 1987; 257 2612-6
50. Oon C J, Tan K L, Goh K T, Wong-Yong L Y M, Viegas O, McCarthy T, et al. Evaluation of a low dose of hepatitis B vaccine given within a childhood immunisation programme in Singapore J Infect 1986; 13:255-67
51. Lee C Y, Hwang L Y, Beasley R P. Low-dose hepatitis B vaccine. Lancet 1989; 2.860-1.
52. Committee on Epidemic Diseases. Immunogenicity of a reduced dose of yeast-derived hepatitis B vaccine and its efficacy in the prevention of perinatal transmission of HBV infection Epidemiol News Bull 1992; 18 47-9.
53. Tan K L, Oon C J, Goh K T, Wong L Y M, Chan S H. Immunogenicity and safety of low doses of recombinant yeast-derived hepatitis B vaccine. Acta Paediatr Scand 1990; 79:593-8
54. Goh K T, Tan K L, Kong K H, Oon C J, Chan S H. Comparison of the immune response of four different dosages of a yeast-recombinant hepatitis B vaccine in Singapore children: a four-year follow-up study. Bull World Health Organ 1992; 70:233-9.
55. Guan R, Tay H H, Yap I, Smith R, Tan L H The immune response of low dose recombinant DNA hepatitis B vaccine in teenagers in Singapore Trans R Soc Trop Med Hyg 1990; 84:731-2
56. Guan R, Tay H H, Yap I, Smith R, Tan L H. Immunogenicity of a low dose recombinant DNA hepatitis B vaccine in healthy adults in Singapore. Asian Pac J Allergy Immunol 1989; 7.85-8.
57. Guan R, Yap I, Tay H H. Hepatitis B vaccination, half dose recombinant DNA hepatitis B vaccine (B-Hepavac) is as immunogenic as the full recommended dose in healthy adults. J Gastroenterol Hepatol 1991; 6:374-6.
58. Oon C J, Chan L, Chan S H, Goh C N, Goh K T, Lim G K, et al Immune status of various populations to hepatitis B virus in Singapore and a strategy for its prevention and immunoprophylaxis Dev Biol Stand 1983; 54 295-303.
59. Goh K T The national childhood immunisation programmes in Singapore. Singapore Med J 1985, 26:225-42
60. Cvjetanovic B, Delimar N, Kosicek M, Likar M, Spoljaric B. Epidemiological model of hepatitis B. Ann Acad Med Singapore 1984; 13:175-84.
61. Cvjetanovic B, Delimar N, Kosicek M, Likar M. Epidemiological model of hepatitis B with age structure Ann Acad Med Singapore 1987; 16:595-607.
62. Goh K T, Doraisingham S, Tan K L, Oon C J, Ho M L, Chen A J, et al. The hepatitis B immunisation programme in Singapore. Bull World Health Organ 1989; 67.65-70.
63. Goh K T. Epidemiology of hepatitis B virus infection in Asean countries-outlook in Singapore In: Chan S H, Ren E C, Tan R J S, editors. Hepatitis B Virus Infection: Current Status and Recent Developments Singapore: Melirwin Enterprises, 1990:87-98.
64. Committee on Epidemic Diseases. Surveillance of post-vaccination adverse reactions. Epidemiol News Bull 1989; 15:13-5.
65. Oon C J, Lim G K, Ye Z, Goh K T, Tan K L, Yo S-L, et al Molecular epidemiology of hepatitis B virus vaccine variants in Singapore Vaccine 1995; 13:699-702
66. Carman W F, Zanetti A R, Karayiannis P E, Waters J, Manzillo G, Tanzi E, et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990; 336:325-9.
67. Zuckerman AJ, Harrison T J, Oon C J. Mutations in the S region of hepatitis B virus. Lancet 1994; 343:737-8.
68. Tan K L, Goh K T, Oon C J, Chan S H. Immunogenicity of recombinant yeast-derived hepatitis B vaccine in nonresponders to perinatal immunisation. JAMA 1994; 271:859-61
69. Committee on Epidemic Diseases. Efficacy of a low-dose plasma-based vaccine in the prevention of HBV carriage in children. Epidemiol News Bull 1990; 16:7-9.
70. Committee on Epidemic Diseases Evaluation of the long-term efficacy of hepatitis B vaccination programme in the prevention of chronic carriage of hepatitis B virus. Epidemiol News Bull 1994; 20:7-10.
71. Weibel R E Hepatitis B vaccine trials: experience and review. In: Millman I, Eisenstein T K, Blumberg B S, editors. Hepatitis B: The Virus, the Disease and the Vaccine. New York: Plenum Press, 1984:161-74.
72. Committee on Epidemic Diseases Long-term immunogenicity and efficacy of areduced dose of yeast-derived hepatitis B vaccine in children Epidemiol News Bull 1996; 22:7-10.
73. Goh K T, Oon C J, Heng B H, Lim G K. Long-term immunogenicity and efficacy of a reduced dose of plasma-based hepatitis B vaccine in young adults. Bull World Health Organ 1995; 73:523-7.
74. Hsu H M, Chen D S, Chuang C H, Lu J C, Jwo D M, Lee C C, et al. Efficacy of a mass hepatitis B vaccination programme in Taiwan: studies on 3464 infants of hepatitis B surface antigen-carrier mothers. JAMA 1988; 260:2231-5.
75. Committee on Epidemic Diseases Seroepidemiology of hepatitis B virus infection in Singapore Epidemiol News Bull 1995; 21:35-7.
76. Kane M Reduced doses of hepatitis B vaccines: is it a good idea? Bull World Health Organ 1995, 73:529-30.
77. Hadler S C, Francis D P, Maynard J E, Thompson S E, Judson F N, Echenberg D F, et al. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N Engl J Med 1986; 315:209-14
78. Expert Committee on Australia Antigen, Ministry of Health, Singapore Australia (hepatitis B) antigen in Singapore: report on the evaluation of blood transfusion practice with respect to Australia (hepatitis B) antigen, October 12, 1973. Singapore. Ministry of Health, 1973.
79. Fong N P, Basir H, Scow A. Awareness and acceptance of hepatitis B vaccination in Clementi, Singapore. Ann Acad Med Singapore 1990; 19:788-92.
80. Oon C J, Lim G K, Tan K L, Harrison T, Zuckerman A. Natural history of hepatitis B surface antigen mutants in children. Lancet 1996; 348:1524.
81. Ong Y W. Some clinical and epidemiological aspects of HBsAg antigenaemia and alpha-feto protein levels in Singapore. In: Liver cancer and cancer problems in Asian countries. Proceedings of the AFOCC 2nd Asian Cancer Conference, Singapore, 1976:57-60.
82. Chan S H. Hepatitis B infection in Singapore. Epidemiol News Bull 1977; 3:15-6.
83. Committee on Epidemic Diseases. Serological survey on hepatitis virus infection in school children in Singapore Epidemiol News Bull 1996; 22:57-9.
84. Chia K S, Lee H P, Seow A, Shanmugaratnam K. Trends in cancer incidence in Singapore 1968-1992. Singapore: Singapore Cancer Registry Report No 4, 1996.
85. Committee on Epidemic Diseases Prevalence of delta virus infection in Singapore. Epidemiol News Bull 1988; 14:11
86. Mah G K, Yeo A. Preimmunisation hepatitis B screening in Singapore - a viewpoint from private sector clinics. Ann Acad Med Singapore 1990; 19:339-43.
87. Chng H H, Fock K M, Chew C N, Guan R, Feng P H, Boey M L, et al. Hepatitis B virus infection in patients with systemic lupus erythematosus. Singapore Med J 1993; 34:325-6.